A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women

Ovulation Inhibition Clinical Trial

Official title:
A Randomized Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering a Daily Dose of 2500 μg of Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel 1.5mg Oral Dose on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to determine the effect of a contraceptive vaginal ring on inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02451826
Study type	Interventional
Source	Population Council
Contact
Status	Active, not recruiting
Phase	Phase 1/Phase 2
Start date	May 2015
Completion date	December 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00567164` - Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ	Phase 3
Completed	`NCT00805415` - Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens	Phase 2
Completed	`NCT00915915` - Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)	Phase 2
Completed	`NCT03077555` - Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception	Phase 4
Recruiting	`NCT02571543` - Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?	Phase 2
Completed	`NCT01031355` - Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium	Phase 1
Terminated	`NCT00729404` - Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene	Phase 2